US Legal Forms
Legal Resources
Questions & Answers
Corporations
Where can I find the address to forward the state copy of FDA form 2579?

Where can I find the address to forward the state copy of FDA form 2579?

Q: Where do I send my i29f?

The Form I-29F, Petition for Alien Fiancé(e), should be sent to the United States Citizenship and Immigration Services (USCIS). The specific mailing address depends on whether you are filing from within the U.S. or abroad. It’s important to check the USCIS website for the most current address and filing instructions.

Q: Where do I send my 2579 form?

You should send your FDA Form 2579 to the appropriate state agency. For Ohio, this is the Bureau of Radiological Health at the Ohio Department of Health, P.O. Box 118, 246 North High Street, Columbus, OH. Always verify the address with your state agency before sending.

Full question:

I need the address to forward the state copy of FDA form 2579.

Category: Corporations
Subcategory: Other
Date: 04/07/2025
State: Ohio

Answer:

Please contact your state agency at:

Bureau of Radiological Health Ohio Department of Health

P.O. Box 118 246 North High Street

Columbus, OH 43266-0118

Roger L. Suppes, Chief Tel: (614) 644-2727 Fax: (614) 466-0381

Keith Shiffman Tel: (614) 752-9154

Becky Shirocos, State Inspector Tel: (614) 644-7216

This content is for informational purposes only and is not legal advice. Legal statutes mentioned reflect the law at the time the content was written and may no longer be current. Always verify the latest version of the law before relying on it.

FAQs

What is a FDA 2579 form?

The FDA Form 2579 is a notification form used by manufacturers and distributors of certain medical devices to report information to the FDA. This form is essential for compliance with FDA regulations regarding the distribution and sale of medical devices. It helps ensure that the FDA can monitor the safety and effectiveness of these products.

What is US FDA Controlled Correspondence?

US FDA Controlled Correspondence refers to formal communications submitted to the FDA regarding regulatory issues, such as inquiries about drug approvals or device regulations. This process allows stakeholders to seek clarification on FDA policies or procedures. Controlled correspondence is critical for ensuring compliance and understanding regulatory expectations.